المؤلفون: Markota M; Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Electronic address: markota.matej@mayo.edu., Croarkin PE; Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Gentry MT; Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Leung JG; Department of Pharmacy, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

المصدر: Schizophrenia research [Schizophr Res] 2024 Jul; Vol. 269, pp. 130-131. Date of Electronic Publication: 2024 May 21.

نوع المنشور: Letter

بيانات الدورية: Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2509 (Electronic) Linking ISSN: 09209964 NLM ISO Abbreviation: Schizophr Res Subsets: MEDLINE

مواضيع طبية MeSH: Electroconvulsive Therapy* , Clozapine*/therapeutic use , Antipsychotic Agents* , Schizophrenia, Treatment-Resistant*/drug therapy , Schizophrenia, Treatment-Resistant*/therapy, Humans ; Adult ; Male ; Female ; Middle Aged ; Schizophrenia/drug therapy ; Schizophrenia/therapy

المؤلفون: Torres-Carmona E; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada., Ueno F; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada., Iwata Y; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Neuropsychiatry, Keio University, Minato, Tokyo, Japan., Nakajima S; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Neuropsychiatry, Keio University, Minato, Tokyo, Japan., Song J; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada., Mar W; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada., Abdolizadeh A; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada., Agarwal SM; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Institute Research Program, CAMH, Toronto, ON, Canada., de Luca V; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Institute Research Program, CAMH, Toronto, ON, Canada., Remington G; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Institute Research Program, CAMH, Toronto, ON, Canada., Gerretsen P; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Institute Research Program, CAMH, Toronto, ON, Canada., Graff-Guerrero A; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Institute Research Program, CAMH, Toronto, ON, Canada. Electronic address: Ariel.Graff@camh.ca.

المصدر: Schizophrenia research [Schizophr Res] 2024 Jul; Vol. 269, pp. 103-113. Date of Electronic Publication: 2024 May 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2509 (Electronic) Linking ISSN: 09209964 NLM ISO Abbreviation: Schizophr Res Subsets: MEDLINE

مواضيع طبية MeSH: Magnetic Resonance Imaging* , Antipsychotic Agents*/pharmacology , Clozapine*/pharmacology , Cerebral Cortex*/diagnostic imaging , Cerebral Cortex*/pathology , Cerebral Cortex*/drug effects , Cerebral Cortex*/physiopathology , Schizophrenia, Treatment-Resistant*/drug therapy , Schizophrenia, Treatment-Resistant*/pathology , Schizophrenia, Treatment-Resistant*/physiopathology , Schizophrenia, Treatment-Resistant*/diagnostic imaging, Humans ; Female ; Male ; Adult ; Middle Aged ; Young Adult ; Schizophrenia/drug therapy ; Schizophrenia/diagnostic imaging ; Schizophrenia/physiopathology ; Schizophrenia/pathology

المؤلفون: Melzer-Ribeiro DL; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil., Napolitano IC; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil., Leite SA; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil., Alencar de Souza JA; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil., Vizzotto ADB; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil., Di Sarno ES; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil., Fortes M; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil., Gomes ML; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil., de Oliveira GM; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil., Avrichir BS; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil., Talib LL; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil., Correll CU; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; Charité - Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany., Elkis H; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil. Electronic address: helkis@usp.br.

المصدر: Schizophrenia research [Schizophr Res] 2024 Jun; Vol. 268, pp. 252-260. Date of Electronic Publication: 2023 Dec 26.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2509 (Electronic) Linking ISSN: 09209964 NLM ISO Abbreviation: Schizophr Res Subsets: MEDLINE

مواضيع طبية MeSH: Electroconvulsive Therapy*/adverse effects , Clozapine*/therapeutic use , Clozapine*/adverse effects , Antipsychotic Agents*/therapeutic use , Schizophrenia, Treatment-Resistant*/therapy , Schizophrenia, Treatment-Resistant*/drug therapy, Humans ; Male ; Female ; Adult ; Double-Blind Method ; Middle Aged ; Psychiatric Status Rating Scales ; Treatment Outcome ; Schizophrenia/therapy ; Schizophrenia/drug therapy ; Outcome Assessment, Health Care

المؤلفون: Kelly DL; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States of America. Electronic address: dlkelly@som.umaryland.edu., Glassman M; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States of America., Wonodi I; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States of America; Sheppard Pratt Health System, Baltimore, MD, United States of America., Vyas G; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States of America; Spring Grove Hospital Center, Catonsville, MD, United States of America., Richardson CM; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States of America; Spring Grove Hospital Center, Catonsville, MD, United States of America., Nwulia E; Howard University Hospital, Washington, DC, United States of America., Wehring HJ; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States of America., Oduguwa T; Federal Neuropsychiatric Hospital Yaba, Lagos, Nigeria., Mackowick M; Clifton T. Perkins Hospital Center, Jessup, MD, United States of America., Hipolito MMS; Howard University Hospital, Washington, DC, United States of America., Peters O; Federal Neuropsychiatric Hospital Yaba, Lagos, Nigeria., Rai N; Howard University Hospital, Washington, DC, United States of America., Park J; Clifton T. Perkins Hospital Center, Jessup, MD, United States of America., Adebayo AO; Federal Neuropsychiatric Hospital Yaba, Lagos, Nigeria., Gorelick DA; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States of America., Weiner E; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States of America., Liu F; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States of America., Kearns AM; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States of America., Adams HA; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States of America; Spring Grove Hospital Center, Catonsville, MD, United States of America., Love RC; University of Maryland School of Pharmacy, Baltimore, MD, United States of America., Chen S; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States of America., Olaniyan A; Federal Neuropsychiatric Hospital Yaba, Lagos, Nigeria., Ambulos N; University of Maryland School of Medicine, Baltimore, MD, United States of America., McKoy D; Howard University Hospital, Washington, DC, United States of America., Nallani MC; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States of America., Lanzkron S; Johns Hopkins University, Baltimore, MD, United States of America., Mengistab M; Howard University Hospital, Washington, DC, United States of America., Barr B; University of Maryland School of Medicine, Baltimore, MD, United States of America., Davis E; University of Maryland School of Pharmacy, Baltimore, MD, United States of America., Lawal R; Federal Neuropsychiatric Hospital Yaba, Lagos, Nigeria., Buchanan RW; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, United States of America., Adebayo R; Federal Neuropsychiatric Hospital Yaba, Lagos, Nigeria.

المصدر: Schizophrenia research [Schizophr Res] 2024 Jun; Vol. 268, pp. 312-322. Date of Electronic Publication: 2023 Aug 24.

نوع المنشور: Journal Article; Multicenter Study; Clinical Trial

بيانات الدورية: Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2509 (Electronic) Linking ISSN: 09209964 NLM ISO Abbreviation: Schizophr Res Subsets: MEDLINE

مواضيع طبية MeSH: Antipsychotic Agents*/administration & dosage , Clozapine*/administration & dosage , Neutrophils*/drug effects , Schizophrenia, Treatment-Resistant*/drug therapy , Schizophrenia, Treatment-Resistant*/genetics, Adult ; Female ; Humans ; Male ; Middle Aged ; Young Adult ; Black People ; Duffy Blood-Group System/genetics ; Leukocyte Count ; Neutropenia/chemically induced ; Neutropenia/genetics ; Prospective Studies ; Receptors, Cell Surface/genetics

المؤلفون: Fernandez-Egea E; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK; Department of Psychiatry, University of Cambridge, UK; and Behavioural and Clinical Neuroscience Institute, University of Cambridge, UK., Chen S; Department of Psychiatry and Division of Psychology and Language Sciences, University College London, UK., Sangüesa E; Faculty of Health Sciences, Universidad San Jorge, Spain., Gassó P; Department of Basic Clinical Practice, University of Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain., Biria M; Behavioural and Clinical Neuroscience Institute, University of Cambridge, UK; and Department of Psychology, University of Cambridge, UK., Plaistow J; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK., Jarratt-Barnham I; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK; Medical Sciences Division, University of Oxford, UK., Segarra N; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK., Mas S; Department of Basic Clinical Practice, University of Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain., Ribate MP; Faculty of Health Sciences, Universidad San Jorge, Spain., García CB; Faculty of Health Sciences, Universidad San Jorge, Spain., Fineberg NA; Hertfordshire Partnership University NHS Foundation Trust, Welwyn Garden City, UK; and School of Life and Medical Sciences, University of Hertfordshire, UK., Worbe Y; Department of Neurophysiology, Sorbonne Université, France; Department of Neurophysiology, Saint-Antoine Hospital, Paris, France; and Institute du Cerveau et de la Moelle Epinière, Paris, France., Cardinal RN; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK; and Department of Psychiatry, University of Cambridge, UK., Robbins TW; Behavioural and Clinical Neuroscience Institute, University of Cambridge, UK; and Department of Psychology, University of Cambridge, UK.

المصدر: The British journal of psychiatry : the journal of mental science [Br J Psychiatry] 2024 May; Vol. 224 (5), pp. 164-169. Date of Electronic Publication: 2024 Apr 23.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Observational Study

بيانات الدورية: Publisher: Cambridge University Press Country of Publication: England NLM ID: 0342367 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-1465 (Electronic) Linking ISSN: 00071250 NLM ISO Abbreviation: Br J Psychiatry Subsets: MEDLINE

مواضيع طبية MeSH: Clozapine*/adverse effects , Clozapine*/therapeutic use , Antipsychotic Agents*/adverse effects , Psychotic Disorders*/drug therapy , Schizophrenia, Treatment-Resistant*/drug therapy , Schizophrenia, Treatment-Resistant*/genetics, Humans ; Male ; Female ; Adult ; Longitudinal Studies ; Middle Aged ; Compulsive Behavior/chemically induced ; Obsessive-Compulsive Disorder/drug therapy ; Obsessive-Compulsive Disorder/chemically induced ; Schizophrenia/drug therapy

المؤلفون: Salahuddin NH; Department of Psychiatry and Psychotherapy, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Schütz A; Department of Psychiatry and Psychotherapy, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Pitschel-Walz G; Institute of General Practice and Health Services Research, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Mayer SF; Department of Psychiatry and Psychotherapy, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Chaimani A; Université Paris Cité, Centre of Research in Epidemiology and Statistics (CRESS-U1153), Inserm, Paris, France., Siafis S; Department of Psychiatry and Psychotherapy, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; German Centre for Mental Health (DZPG), Munich and Augsburg, Germany., Priller J; Department of Psychiatry and Psychotherapy, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; German Centre for Mental Health (DZPG), Munich and Augsburg, Germany; Neuropsychiatry and Laboratory of Molecular Psychiatry, Charité-Universitätsmedizin Berlin and DZNE, Berlin, Germany; University of Edinburgh and UK DRI, Edinburgh, UK., Leucht S; Department of Psychiatry and Psychotherapy, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; German Centre for Mental Health (DZPG), Munich and Augsburg, Germany. Electronic address: stefan.leucht@tum.de., Bighelli I; Department of Psychiatry and Psychotherapy, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; German Centre for Mental Health (DZPG), Munich and Augsburg, Germany.

المصدر: The lancet. Psychiatry [Lancet Psychiatry] 2024 Jul; Vol. 11 (7), pp. 545-553.

نوع المنشور: Journal Article; Systematic Review; Meta-Analysis

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101638123 Publication Model: Print Cited Medium: Internet ISSN: 2215-0374 (Electronic) Linking ISSN: 22150366 NLM ISO Abbreviation: Lancet Psychiatry Subsets: MEDLINE

مواضيع طبية MeSH: Network Meta-Analysis* , Psychosocial Intervention*/methods , Schizophrenia, Treatment-Resistant*/therapy, Humans ; Randomized Controlled Trials as Topic ; Psychotherapy/methods ; Antipsychotic Agents/therapeutic use ; Treatment Outcome ; Schizophrenia/therapy

المؤلفون: Agid O; Centre for Addiction and Mental Health, University of Toronto, Canada., Crespo-Facorro B; Department of Psychiatry, School of Medicine, University Hospital Virgen del Rocío-IBiS-CSIC, Sevilla, Spain, Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Sevilla, Spain., de Bartolomeis A; University of Naples Federico II, Department of Neuroscience, Reproductive Science, and Odontostomatology. Laboratory of Molecular and Translational Psychiatry. Unit of Treatment Resistant Psychosis, Naples, Italy; Staff Unesco Chair at University of Naples Federico II, Italy., Fagiolini A; University of Siena, Siena, Italy., Howes OD; IoPPN, King's College London, De Crespigny Park, London, United Kingdom; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London, United Kingdom., Seppälä N; Wellbeing Services in Satakunta, Department of Psychiatry, Pori, Finland and Medical Consultant, Viatris, Finland., Correll CU; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, New York, United States; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, New York, United States; Charité - Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Augustenburger Platz 1, Berlin 13353, Germany; German Center for Mental Health (DZPG), Partner Site Berlin, Berlin, Germany. Electronic address: christoph.correll@charite.de.

المصدر: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2024 Jul; Vol. 84, pp. 35-47. Date of Electronic Publication: 2024 Apr 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9111390 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7862 (Electronic) Linking ISSN: 0924977X NLM ISO Abbreviation: Eur Neuropsychopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Clozapine*/therapeutic use , Clozapine*/adverse effects , Antipsychotic Agents*/therapeutic use , Antipsychotic Agents*/adverse effects , Schizophrenia, Treatment-Resistant*/drug therapy, Humans ; Health Services Accessibility ; Schizophrenia/drug therapy

المؤلفون: Siafis S; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Munich, Germany. spyridon.siafis@tum.de., Lorenz C; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Munich, Germany., Wu H; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Munich, Germany., Zhu Y; Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Schneider-Thoma J; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Munich, Germany., Bighelli I; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Munich, Germany., Li C; Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Institute of Psychology and Behavioral Science, Shanghai Jiao Tong University, Shanghai, China., Hansen WP; BASTA-Das Bündnis Für Psychisch Erkrankte Menschen, Munich, Germany., Padberg F; Department of Psychiatry and Psychotherapy, LMU University Hospital Munich, Munich, Germany., Salanti G; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland., Leucht S; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Munich, Germany.

المصدر: Systematic reviews [Syst Rev] 2024 Jun 24; Vol. 13 (1), pp. 165. Date of Electronic Publication: 2024 Jun 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101580575 Publication Model: Electronic Cited Medium: Internet ISSN: 2046-4053 (Electronic) Linking ISSN: 20464053 NLM ISO Abbreviation: Syst Rev Subsets: MEDLINE

مواضيع طبية MeSH: Systematic Reviews as Topic* , Network Meta-Analysis* , Schizophrenia, Treatment-Resistant*/therapy , Transcranial Direct Current Stimulation*/methods, Humans ; Antipsychotic Agents/therapeutic use ; Transcranial Magnetic Stimulation/methods ; Meta-Analysis as Topic ; Randomized Controlled Trials as Topic ; Schizophrenia/therapy

المؤلفون: Honigfeld G; Department of Psychology, William Paterson University, Wayne, NJ, USA. Electronic address: honigfeldg@wpunj.edu.

المصدر: Schizophrenia research [Schizophr Res] 2024 Jun; Vol. 268, pp. 7-8. Date of Electronic Publication: 2023 Aug 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2509 (Electronic) Linking ISSN: 09209964 NLM ISO Abbreviation: Schizophr Res Subsets: MEDLINE

مواضيع طبية MeSH: Clozapine*/therapeutic use , Antipsychotic Agents*/therapeutic use , Schizophrenia, Treatment-Resistant*/drug therapy, Humans ; United States ; Clinical Trials as Topic ; Schizophrenia/drug therapy

المؤلفون: Kane JM; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; The Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Manhasset, NY, USA., Schoretsanitis G; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; The Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Manhasset, NY, USA; Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland. Electronic address: george.schor@gmail.com., Rubio JM; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; The Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Manhasset, NY, USA., Correll CU; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; The Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Manhasset, NY, USA; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany; German Center for Mental Health (DZPG), partner site Berlin, Germany.

المصدر: Schizophrenia research [Schizophr Res] 2024 Jun; Vol. 268, pp. 9-13. Date of Electronic Publication: 2024 Jan 29.

نوع المنشور: Letter; Journal Article

بيانات الدورية: Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2509 (Electronic) Linking ISSN: 09209964 NLM ISO Abbreviation: Schizophr Res Subsets: MEDLINE

مواضيع طبية MeSH: Clozapine*/therapeutic use , Antipsychotic Agents*/therapeutic use , Antipsychotic Agents*/pharmacology , Schizophrenia, Treatment-Resistant*/drug therapy, Humans ; United States ; Schizophrenia/drug therapy